1.9(top 9%)
Impact Factor
2.1(top 9%)
extended IF
97(top 4%)
H-Index
6.3K
authors
12.7K
papers
166.5K
citations
5.8K
citing journals
56.6K
citing authors

Most Cited Articles of Leukemia and Lymphoma

TitleYearCitations
Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F2001247
Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management2000238
CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy1995226
Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China2002225
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT2000222
Management of adverse events associated with idelalisib treatment: expert panel opinion2015221
Rituximab-related viral infections in lymphoma patients2007209
Granulocytic sarcoma: 32 cases and review of the literature2006200
Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib2008199
Preclinical versus clinical drug combination studies2008187
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma2013177
Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy2003177
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma2008174
Improved outcome of zygomycosis in patients with hematological diseases?2004171
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases2011168
Mastocytosis: pathology, genetics, and current options for therapy2005165
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia2002163
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98)2004161
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel2011160
Hematopoeitic stem cell transplantation for adult T cell leukemia-lymphoma: Who is the best candidate?2017157
Renal failure in multiple myeloma: incidence, correlations, and prognostic significance2007153
L-asparaginase and PEG asparaginase--past, present, and future1993152
Epidemiology of myeloproliferative neoplasms in the United States2014149
Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia2008146
Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines1993146